DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Kokomo, IN

5 verified pulmonary disease doctors in Kokomo.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Indiana Medical Licensing Board

Dr. James Downing, MD

Pulmonary Disease

21 yrs NPPES
NPI 1225019714
3504 S LAFOUNTAIN ST, Kokomo, IN 46902(765) 865-6600
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Mohammad Tariq, MD

Pulmonary Disease

19 yrs NPPES
NPI 1386792521
3504 S LAFOUNTAIN ST, Kokomo, IN 46902(765) 865-6600
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $232.30 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$232.30

Total received

12

Transactions

9

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$61.67
GlaxoSmithKline, LLC.$29.67
AbbVie Inc.$29.17
NOVARTIS PHARMACEUTICALS CORPORATION$20.72
Takeda Pharmaceuticals U.S.A., Inc.$19.52
Grifols USA, LLC$19.44

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 66th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mohammad Tariq do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Sodienye Tetenta, MD

Pulmonary Disease

19 yrs NPPES
NPI 1447459763
1907 W SYCAMORE ST, Kokomo, IN 46901(765) 236-8363
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Daniel Livingston, MD

Pulmonary Disease

15 yrs NPPES
NPI 1902105687
3504 S LAFOUNTAIN ST, Kokomo, IN 46902(765) 776-3600
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $737.39 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$737.39

Total received

33

Transactions

15

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$212.74
GlaxoSmithKline, LLC.$137.78
Boehringer Ingelheim Pharmaceuticals, Inc.$52.87
Amgen Inc.$43.69
NOVARTIS PHARMACEUTICALS CORPORATION$42.77
Mylan Specialty L.P.$40.78

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 77th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Daniel Livingston do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Min Clapham, DO

Pulmonary Disease

14 yrs NPPES
NPI 1881957207
1907 W SYCAMORE ST, Kokomo, IN 46901(765) 236-8363
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,520 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,520

Total received

44

Transactions

13

Paying companies

Top paying companies

Regeneron Healthcare Solutions, Inc.$1,679
GlaxoSmithKline, LLC.$265.38
AstraZeneca Pharmaceuticals LP$188.19
Gilead Sciences, Inc.$133.95
Boehringer Ingelheim Pharmaceuticals, Inc.$55.63
Takeda Pharmaceuticals U.S.A., Inc.$39.10

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Min Clapham do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Kokomo, IN — Verified | DoctorsProof | DoctorsProof